Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis

Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis has published recently in Hepat Mon by Alavian et al: Abstract Context: Direct acting antivirals (DAAs) have recently emerged as a promising therapeutic regimen for the treatment of hepatitis C virus (HCV) infection, which is a major…

Read More

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline has published recently in Hepat Mon by Alavian et al:  Abstract Context: Hepatitis C virus (HCV) infection is a major public health issue worldwide, including Iran. The new direct-acting antiviral agents (DAAs) with high efficacy have…

Read More

Hepatitis C vaccine development shows progress but scientific barriers remain

12 September 2016 An effective vaccine may be necessary to eliminate hepatitis C virus (HCV) but development has been hampered by several challenges including the variability of the virus and incomplete natural immunity, according to presentations at the 5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016) last…

Read More

Nice Article from Thailand about coverage of HCV treatment

Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era. By Poovorawan K et al in:  PLoS One. 2016 Sep 15;11(9):e0163095. doi: 10.1371/journal.pone.0163095. Abstract Hepatitis C virus (HCV) infection is an important worldwide public health problem, and most of the…

Read More

Jordan is low endemicity for HCV infection in Middle East Region

Jordan is low endemicity for HCV infection in Middle East Region   Seroprevalence rates of transfusion-transmitted infections among blood donors in Jordan. By Souan L in J Infect Dev Ctries. 2016 Apr 28;10(4):377-83 Abstract INTRODUCTION: Statistics on the prevalence of donor screening for hepatitis B surface antigen (HBsAg) and anti-hepatitis…

Read More

New Publication from Rwanda about HCV therapy experience

Hepatitis C treatment outcomes using Interferon- and Ribavirin-based therapy in Kigali, Rwanda. By Riedel DJ et al in Trans R Soc Trop Med Hyg. 2016 Sep 12. Abstract BACKGROUND: Hepatitis C virus (HCV) treatment data in sub-Saharan Africa are limited. This study was to determine HCV sustained virologic response(SVR) at…

Read More